Concepedia

James L. Freddo

JL

15

Publications

1.4K

Citations

13

H-Index

1993

Active since

Affiliations

University of California San Diego(Current)

Erasmus MC

Pfizer (United States)

Seno Medical (United States)

Clinical Research Institute

James L. Freddo is an author at University of California San Diego specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1993–2021

15

Publications

15

Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results

Hope S. Rugo, Roy S. Herbst, Glenn Liu et al. · Journal of Clinical Oncology · 2005 · 485 citations · Full text

Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study

Olivier Rixe, Ronald M. Bukowski, M. Dror Michaelson et al. · The Lancet Oncology · 2007 · 434 citations

, , +5

Cytoreductive Surgery in Advanced Epithelial Cancer of the Ovary: The Impact of Aortic and Pelvic Lymphadenectomy

Nick M. Spirtos, Gary M. Gross, James L. Freddo et al. · Gynecologic Oncology · 1995 · 103 citations

, , +8

Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer.

Steven C. Plaxe, Patricia S. Braly, James L. Freddo et al. · PubMed · 1993 · 66 citations

Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV

Jean‐François Bergmann, Joep de Bruijne, Daphne M. Hotho et al. · Alimentary Pharmacology & Therapeutics · 2011 · 52 citations · Full text

Rows per page

1–5 of 15